The Anti-Cardiolipin Screen is a semi-quantitative immunoassay for the determination of IgG, IgM and IgA antibodies against nuclear and cytoplasmic antigens in human serum. The Anti-Cardiolipin Screen is intended as an aid in the diagnosis of anti-phospholipid antibody syndrome (APAS) in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
4014 – Anti-Cardiolipin Screen
Autoimmunity, Diagnostics, ELISA
4014 – Anti-Cardiolipin Screen
Enzyme immunoassay for the semi-quantitative determination of IgG, IgM and IgA antibodies against Cardiolipin in human serum
Available Downloads:
| Indication | Anti-phospholipid syndrome (APAS) |
|---|---|
| Format | Microtiter plate coated with cardiolipin complex |
| Total incubation time | 105 min. |
| No. of determinations | 96 (93 x 1) + 1 x Calibrator + 2 x Controls |
Related products
-
8064 – CytoBead® CeliAK
Indirect immunofluorescence assay for the qualitative and semi-quantitative determination of IgA or IgG antibodies in human serum against endomysium, tissue transglutaminase (tTG) and deamidated gliadin (DG) as well as for control of IgA antibodies
-
3850 – Anti-GP2 IgG
Enzyme immunoassay for the quantitative determination of IgG antibodies against glycoprotein 2 in human serum
-
3950 – Pancreatitis GP2
Enzyme immunoassay for the quantitative determination of glycoprotein 2 (GP2) in human serum